AXSM
Axsome Therapeutics, Inc.Company with tickers: AXSM
CIK
1579428
CUSIP
05464T104
Shares Outstanding
51,459,766
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $191,203,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $52,677,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| Operating Income | $-63,357,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| Net Income | $-64,542,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| EPS (Basic) | $-1.26 | USD/shares | 2026-03-31 | 10-Q | 2026-05-04 |
| EPS (Diluted) | $-1.26 | USD/shares | 2026-03-31 | 10-Q | 2026-05-04 |